XAGE Stock Chart & Stats
$0.31
--
Market closed
$0.31
--
Day’s Range― - ―
52-Week Range$0.23 - $8.27
Previous CloseN/A
VolumeN/A
Average Volume (3M)25.88K
Market Cap
$559.42K
Enterprise Value$513.17K
Total Cash (Recent Filing)$313.40K
Total Debt (Recent Filing)$400.62K
Price to Earnings (P/E)―
Beta0.90
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.88
Shares Outstanding2,475,321
10 Day Avg. Volume7,273
30 Day Avg. Volume25,877
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.09
Price to Sales (P/S)0.27
P/FCF Ratio-0.16
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue0.29
Enterprise Value/Gross Profit0.50
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Longevity Health Holdings News
XAGE FAQ
What was Longevity Health Holdings’s price range in the past 12 months?
Longevity Health Holdings lowest stock price was $0.23 and its highest was $8.27 in the past 12 months.
What is Longevity Health Holdings’s market cap?
Longevity Health Holdings’s market cap is $559.42K.
When is Longevity Health Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Longevity Health Holdings’s earnings last quarter?
Currently, no data Available
Is Longevity Health Holdings overvalued?
According to Wall Street analysts Longevity Health Holdings’s price is currently Overvalued.
Does Longevity Health Holdings pay dividends?
Longevity Health Holdings does not currently pay dividends.
What is Longevity Health Holdings’s EPS estimate?
Longevity Health Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Longevity Health Holdings have?
Longevity Health Holdings has 2,475,321 shares outstanding.
What happened to Longevity Health Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Longevity Health Holdings?
Currently, no hedge funds are holding shares in XAGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Longevity Health Holdings
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds. Established in 2008, the company maintains its headquarters in Pittsburgh, Pennsylvania.
Technical Analysis
Ownership Overview
27.86% Insiders
0.57% Other Institutional Investors
71.57% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---